Taysha Gene Therapies, Inc. 宣布,其针对REVEAL 1/2期临床试验A部分所获得的更长周期安全性与有效性数据更新,预计将在2026年上半年对外公布。
Taysha Gene Therapies, Inc. 宣布,其针对REVEAL 1/2期临床试验A部分所获得的更长周期安全性与有效性数据更新,预计将在2026年上半年对外公布。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.